Cargando…

Peritoneal dialysis as a treatment option in autosomal dominant polycystic kidney disease

PURPOSE: When choosing a dialysis option for ADPKD patients, peritoneal dialysis (PD) is often discouraged, due to its potential drawbacks: risk of abdominal hernias and dialysis fluid leaks, risk of peritonitis and insufficient dialysis adequacy. The present study was designed to compare the outcom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jankowska, Magdalena, Chmielewski, Michał, Lichodziejewska-Niemierko, Monika, Jagodziński, Piotr, Rutkowski, Bolesław
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2015
Materias:	Nephrology - Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600724/ https://www.ncbi.nlm.nih.gov/pubmed/26282281 http://dx.doi.org/10.1007/s11255-015-1087-9

Ejemplares similares

Impact of gender and dialysis adequacy on anaemia in peritoneal dialysis
por: Ryta, Alicja, et al.
Publicado: (2017)

Influence of megestrol acetate on nutrition, inflammation and quality of life in dialysis patients
por: Gołębiewska, Justyna E., et al.
Publicado: (2011)

Plant-derived compounds for treating autosomal dominant polycystic kidney disease
por: Zhang, Jieting, et al.
Publicado: (2023)

Determinants of anxiety in patients with advanced somatic disease: differences and similarities between patients undergoing renal replacement therapies and patients suffering from cancer
por: Janiszewska, Justyna, et al.
Publicado: (2012)

Umbilical hernia in autosomal dominant polycystic kidney disease
por: Hattori, Yoshinari, et al.
Publicado: (2014)

The Effect of Dietary Intervention on Autosomal-Dominant Polycystic Kidney Disease (ADPKD) Patients on Tolvaptan and Their Quality of Life
por: Tarabzuni, Ola
Publicado: (2022)

Outcomes from the Northeast England cohort of autosomal dominant polycystic kidney disease (ADPKD) patients on tolvaptan
por: Gkekas, Eleftherios, et al.
Publicado: (2022)

Sturge–Weber syndrome coexisting with autosomal dominant polycystic kidney disease
por: Niemczyk, Mariusz, et al.
Publicado: (2012)

Twenty-Year Survival of Kidney Transplant From a Deceased Donor With Autosomal Dominant Polycystic Kidney Disease
por: Issa, Naim, et al.
Publicado: (2021)

Healthcare Resource Utilization and Costs Associated with Autosomal Dominant Polycystic Kidney Disease
por: Blanchette, Christopher M., et al.
Publicado: (2014)

Optimizing peritoneal dialysis catheter placement
por: Khan, Sana F., et al.
Publicado: (2023)

Efficacy and safety of tolvaptan versus placebo in the treatment of patients with autosomal dominant polycystic kidney disease: a meta-analysis
por: Lu, Jingkui, et al.
Publicado: (2022)

The optimization of peritoneal dialysis training in long-term
por: Gursu, Meltem, et al.
Publicado: (2023)

Incremental peritoneal dialysis after unplanned start initiation
por: Calice-Silva, Viviane, et al.
Publicado: (2022)

Obesity, Weight Gain, and Fluid Overload in Peritoneal Dialysis
por: Ng, Jack Kit-Chung, et al.
Publicado: (2022)

Parasympathetic activity and total fibrotic kidney in autosomal-dominant polycystic kidney disease patients: a pilot study
por: Lai, Silvia, et al.
Publicado: (2023)

Multiple Cerebral Aneurysms in an Adult With Autosomal Recessive Polycystic Kidney Disease
por: Gately, Ryan, et al.
Publicado: (2020)

Chronic Kidney Disease Education Class Improves Rates of Early Access Creation and Peritoneal Dialysis Enrollment
por: Aloudah, Saud A, et al.
Publicado: (2022)

Atypical Clinical Presentation of Autosomal Recessive Polycystic Kidney Mimicking Medullary Sponge Kidney Disease
por: Letavernier, Emmanuel, et al.
Publicado: (2021)

Peritonitis from Anaerobic Gram-positive Cocci Likely Due to Translocation of Bacteria from Gut in a Patient Undergoing Peritoneal Dialysis
por: Adapa, Sreedhar, et al.
Publicado: (2019)

Sclerostin─A Debutant on the Autosomal Dominant Polycystic Kidney Disease Scene?
por: Jankowska, Magdalena, et al.
Publicado: (2017)

Abdominal Aortic Dissection in a Patient With Autosomal Dominant Polycystic Kidney Disease After Starting Peritoneal Dialysis()
por: He, Yingying, et al.
Publicado: (2014)

Relationship Between Serum Total Carbon Dioxide Concentration and Bicarbonate Concentration in Patients Undergoing Peritoneal Dialysis
por: Hirai, Keiji, et al.
Publicado: (2021)

Interventions to improve the well-being of family caregivers of patients on hemodialysis and peritoneal dialysis: a systematic review
por: Hovadick, Ana Carolina, et al.
Publicado: (2021)

Pretransplant Nephrectomy for Large Polycystic Kidneys in ADPKD (Autosomal Dominant Polycystic Kidney Disease) Patients: Is Peritoneal Dialysis Recovery Possible after Surgery?
por: Ietto, Giuseppe, et al.
Publicado: (2019)

Peritoneal Dialysis Catheter−Fallopian Tube Fistula
por: Mandalapu, Rajendra, et al.
Publicado: (2020)

A Case Report of Autosomal Dominant Polycystic Kidney Disease Under Peritoneal Dialysis With Cyst Infection and Culture-Positive Peritoneal Fluid
por: Yasuda, Itaru, et al.
Publicado: (2019)

Autosomal dominant polycystic kidney
por: Gudadhe, Rugaved Raghavendra, et al.
Publicado: (2022)

Autosomal dominant polycystic kidney disease complicating renal ectopia and managed with renal transplantation
por: Connor, Andrew, et al.
Publicado: (2009)

Laparoscopic Sleeve Gastrectomy in a Patient on Peritoneal Dialysis
por: Nguyen, Anthony Hoan, et al.
Publicado: (2020)

Application of automated peritoneal dialysis in urgent-start peritoneal dialysis patients during the break-in period
por: Liu, Shengmao, et al.
Publicado: (2018)

Dialysate copeptin and peritoneal transport in incident peritoneal dialysis patients
por: Fijałkowski, Maciej, et al.
Publicado: (2019)

Diagnostic Imaging of Autosomal Dominant Polycystic Kidney Disease
por: Gradzik, Monika, et al.
Publicado: (2016)

Comparative effectiveness of lactulose and sennosides for the prevention of peritoneal dialysis-related peritonitis: an open-label, randomized, active-controlled trial
por: Noppakun, Kajohnsak, et al.
Publicado: (2021)

Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
por: Radhakrishnan, Yeshwanter, et al.
Publicado: (2022)

Biliary peritonitis due to liver cyst rupture in autosomal dominant polycystic kidney disease
por: Matsuo, Hiroshi, et al.
Publicado: (2021)

Polycystic horseshoe kidney
por: Prasad, A. K., et al.
Publicado: (2013)

COVID-19 vaccination in peritoneal dialysis patients
por: Htay, Htay, et al.
Publicado: (2022)

Noninfectious Peritoneal Dialysis Exit Site Rash—An Unusual Case Report and Review of the Literature
por: Siddiqui, Mohammed, et al.
Publicado: (2017)

Endocarditis-Associated C3-Dominant Glomerulonephritis in a Patient With a Solitary Kidney
por: Chowdhury, Lynda, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_opgeeu0jn8rvleg876f20s2gs8